Yesterday, Nov. 9, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,037.40 to $6,950,097.00.

Highlighted Stocks Traded by Insiders:

F N B (FNB) - FREE Research Report

Stanik John S, who is Director at F N B, bought 2,200 shares at $14.46 on Nov. 9, 2015. Following this transaction, the Director owned 22,286 shares meaning that the stake was boosted by 10.95% with the 2,200-share transaction.

The shares most recently traded at $14.42, down $0.04, or 0.25% since the insider transaction. Historical insider transactions for F N B go as follows:

  • 4-Week # shares bought: 3,900
  • 4-Week # shares sold: 1,700
  • 12-Week # shares bought: 3,900
  • 12-Week # shares sold: 25,700
  • 24-Week # shares bought: 3,900
  • 24-Week # shares sold: 1,700

The average volume for F N B has been 1.3 million shares per day over the past 30 days. F N B has a market cap of $2.5 billion and is part of the financial sector and banking industry. Shares are up 8.03% year-to-date as of the close of trading on Monday.

F.N.B. Corporation, a financial holding company, provides various financial services to consumers, corporations, governments, and small- to medium-sized businesses primarily in Pennsylvania, eastern Ohio, and northern West Virginia. The stock currently has a dividend yield of 3.31%. The company has a P/E ratio of 16.8. Currently, there are 2 analysts who rate F N B a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FNB - FREE

TheStreet Quant Ratings

rates F N B as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, expanding profit margins and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

F N B Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Neogen (NEOG) - FREE Research Report

Bradley Edward, who is Vice President at Neogen, sold 15,700 shares at $55.62 on Nov. 9, 2015. Following this transaction, the Vice President owned 122,530 shares meaning that the stake was reduced by 11.36% with the 15,700-share transaction.

The shares most recently traded at $55.34, down $0.28, or 0.51% since the insider transaction. Historical insider transactions for Neogen go as follows:

  • 4-Week # shares bought: 5,060
  • 4-Week # shares sold: 44,300
  • 12-Week # shares bought: 5,060
  • 12-Week # shares sold: 44,300
  • 24-Week # shares bought: 5,560
  • 24-Week # shares sold: 56,140

The average volume for Neogen has been 195,500 shares per day over the past 30 days. Neogen has a market cap of $2.1 billion and is part of the health care sector and drugs industry. Shares are up 11.84% year-to-date as of the close of trading on Monday.

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products and services for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The company has a P/E ratio of 61.6. Currently, there are 2 analysts who rate Neogen a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NEOG - FREE

TheStreet Quant Ratings

rates Neogen as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and solid stock price performance. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Neogen Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Chesapeake Lodging (CHSP) - FREE Research Report

Wootten Graham J., who is SVP, CAO & Secretary at Chesapeake Lodging, bought 930 shares at $27.25 on Nov. 9, 2015. Following this transaction, the SVP, CAO & Secretary owned 77,072 shares meaning that the stake was boosted by 1.22% with the 930-share transaction.

The shares most recently traded at $27.70, up $0.45, or 1.62% since the insider transaction. Historical insider transactions for Chesapeake Lodging go as follows:

  • 4-Week # shares bought: 14,500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 14,500
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 20,500
  • 24-Week # shares sold: 10,000

The average volume for Chesapeake Lodging has been 382,000 shares per day over the past 30 days. Chesapeake Lodging has a market cap of $1.7 billion and is part of the financial sector and real estate industry. Shares are down 25.91% year-to-date as of the close of trading on Monday.

Chesapeake Lodging Trust is a self-advised real estate investment trust organized in the state of Maryland in June 2009. The company focuses on investments primarily in upper-upscale hotels in major business and convention markets and premium select-service hotels in urban settings or unique locations in the United States. The stock currently has a dividend yield of 5.72%. The company has a P/E ratio of 31.4. Currently, there are 3 analysts who rate Chesapeake Lodging a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHSP - FREE

TheStreet Quant Ratings

rates Chesapeake Lodging as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Chesapeake Lodging Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.